These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 11069077

  • 1. A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regions.
    Spendlove L, Li L, Potter V, Christiansen D, Loveland BE, Durrant LG.
    Eur J Immunol; 2000 Oct; 30(10):2944-53. PubMed ID: 11069077
    [Abstract] [Full Text] [Related]

  • 2. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
    Maruyama H, Zaloudik J, Li W, Sperlagh M, Koido T, Somasundaram R, Scheck S, Prewett M, Herlyn D.
    Cancer Immunol Immunother; 2000 Jun; 49(3):123-32. PubMed ID: 10881691
    [Abstract] [Full Text] [Related]

  • 3. A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55.
    Ullenhag GJ, Spendlove I, Watson NF, Indar AA, Dube M, Robins RA, Maxwell-Armstrong C, Scholefield JH, Durrant LG.
    Clin Cancer Res; 2006 Dec 15; 12(24):7389-96. PubMed ID: 17121873
    [Abstract] [Full Text] [Related]

  • 4. A neoadjuvant clinical trial in colorectal cancer patients of the human anti-idiotypic antibody 105AD7, which mimics CD55.
    Durrant LG, Maxwell-Armstrong C, Buckley D, Amin S, Robins RA, Carmichael J, Scholefield JH.
    Clin Cancer Res; 2000 Feb 15; 6(2):422-30. PubMed ID: 10690519
    [Abstract] [Full Text] [Related]

  • 5. Decay accelerating factor (CD55): a target for cancer vaccines?
    Spendlove I, Li L, Carmichael J, Durrant LG.
    Cancer Res; 1999 May 15; 59(10):2282-6. PubMed ID: 10344729
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies.
    Burlingham WJ, Jankowska-Gan E, DeVito-Haynes L, Fechner JH, Hogan KT, Claas FH, Mulder A, Wang X, Ferrone S.
    J Immunol; 1998 Dec 15; 161(12):6705-14. PubMed ID: 9862700
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Specific lysis of melanoma cells by receptor grafted T cells is enhanced by anti-idiotypic monoclonal antibodies directed to the scFv domain of the receptor.
    Reinhold U, Liu L, Lüdtke-Handjery HC, Heuser C, Hombach A, Wang X, Tilgen W, Ferrone S, Abken H.
    J Invest Dermatol; 1999 May 15; 112(5):744-50. PubMed ID: 10233766
    [Abstract] [Full Text] [Related]

  • 11. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
    Foon KA, Oseroff AR, Vaickus L, Greenberg SJ, Russell D, Bernstein Z, Pincus S, Köhler H, Seon BK, Tahaoglu E.
    Clin Cancer Res; 1995 Nov 15; 1(11):1285-94. PubMed ID: 9815923
    [Abstract] [Full Text] [Related]

  • 12. Human monoclonal anti-idiotypic antibody to the tumour-associated antibody 791T/36.
    Austin EB, Robins RA, Durrant LG, Price MR, Baldwin RW.
    Immunology; 1989 Aug 15; 67(4):525-30. PubMed ID: 2788611
    [Abstract] [Full Text] [Related]

  • 13. Molecular basis of antigen mimicry by an anti-idiotope.
    Fields BA, Goldbaum FA, Ysern X, Poljak RJ, Mariuzza RA.
    Nature; 1995 Apr 20; 374(6524):739-42. PubMed ID: 7536303
    [Abstract] [Full Text] [Related]

  • 14. Structural profile of idiotype, anti-idiotype and anti-anti-idiotype monoclonal antibodies in the HLA-DQ3 antigenic system.
    Iwasaki Y, Takabatake H, Shinji T, Monestier M, Ferrone S.
    Eur J Immunol; 1994 Nov 20; 24(11):2874-81. PubMed ID: 7957578
    [Abstract] [Full Text] [Related]

  • 15. Immunomodulatory activity of monoclonal anti-idiotypic antibody to anti-colorectal carcinoma antibody CO17-1A in animals and patients.
    Herlyn D, Harris D, Zaloudik J, Sperlagh M, Maruyama H, Jacob L, Kieny MP, Scheck S, Somasundaram R, Hart E.
    J Immunother Emphasis Tumor Immunol; 1994 May 20; 15(4):303-11. PubMed ID: 8061902
    [Abstract] [Full Text] [Related]

  • 16. A genetic approach to idiotypic vaccination for B cell lymphoma.
    Stevenson FK, Zhu D, King CA, Ashworth LJ, Kumar S, Thompsett A, Hawkins RE.
    Ann N Y Acad Sci; 1995 Nov 27; 772():212-26. PubMed ID: 8546396
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.
    Reinartz S, Hombach A, Köhler S, Schlebusch H, Wallwiener D, Abken H, Wagner U.
    Cancer Res; 2003 Jun 15; 63(12):3234-40. PubMed ID: 12810653
    [Abstract] [Full Text] [Related]

  • 18. Chimerization of LL2, a rapidly internalizing antibody specific for B cell lymphoma.
    Leung SO, Shevitz J, Pellegrini MC, Dion AS, Shih LB, Goldenberg DM, Hansen HJ.
    Hybridoma; 1994 Dec 15; 13(6):469-76. PubMed ID: 7737671
    [Abstract] [Full Text] [Related]

  • 19. 105Ad7 cancer vaccine stimulates anti-tumour helper and cytotoxic T-cell responses in colorectal cancer patients but repeated immunisations are required to maintain these responses.
    Durrant LG, Buckley DJ, Robins RA, Spendlove I.
    Int J Cancer; 2000 Jan 01; 85(1):87-92. PubMed ID: 10585589
    [Abstract] [Full Text] [Related]

  • 20. Molecular mimicry of carcinoembryonic antigen by peptides derived from the structure of an anti-idiotype antibody.
    Chatterjee SK, Tripathi PK, Chakraborty M, Yannelli J, Wang H, Foon KA, Maier CC, Blalock JE, Bhattacharya-Chatterjee M.
    Cancer Res; 1998 Mar 15; 58(6):1217-24. PubMed ID: 9515808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.